Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease

Cited by (685)

Items 601–685 of 685

1. The Role of Inflammation in the Brain: A Gut-Driven Phenomenon
   Nasir Uddin Mahbub, Md Minarul Islam, Seong Tshool Hong · 2026 · Springer eBooks
2. Decoding Pathogenic Mutational Landscapes in Alzheimer′s Disease Through Integrated Transcriptomics
   Wan Ma, Fenfang Zhou, Huaying Cai, Ling Fang · 2026 · Human Mutation
3. Formation and toxicity of protein misfolded oligomers: Mechanistic insights and therapeutic opportunities in protein aggregation diseases
   Lorenzo Neri, Carol A. Anderson, Lucas B. Fallot, Benedetta Mannini, Ryan Limbocker · 2026 · Elsevier eBooks
4. Green Coffee Bean Extract Mitigates Alzheimer’s Disease in Male Rats
   Amal S. Abu-Almakarem, Othman R. Alzahrani, Rasha Abu‐Khudir, S. R. Alassar, Karim Samy El-Said, Sahar Abdulrahman Alkhodair, Abeer A. Banjabi, Maha Mohammed Al-Bazi, Maysa Ahmed Mobasher, Mohamed Mostafa Soliman · 2026 · Journal of Food Biochemistry
5. Translational Feasibility of Curcumin for Treatment of Alzheimer’s Disease: A Critical Appraisal of Clinical Challenges
   Jasmine Priya Virk, Malika G. Fernando, Prita Riana Asih, Ralph Nigel Martins · 2026 · Antioxidants
6. New Adjuvant Therapies for Obesity-Related Disorders Associated with Meta-Neuroinflammation
   Flaminia Coluzzi, Kevin Cornali, Maria Sole Scerpa, Annalisa Noce · 2026 · Pharmaceuticals
7. Neurovascular coupling and energy substrate delivery in Alzheimer’s disease
   Shivam Malviya, Debasmita Saha, Anagha Kamble, Divya Ramesh Singh, Sivaraj Mohana Sundaram, Vasudharani Devanathan · 2026 · International review of neurobiology
8. Microenvironmental Regulation of Central Nervous System Myelination and Remyelination
   Yuxuan Wang, Lingzhen Tan, Lin Lao, Xiaomeng Huang, Sheng Zhang, Sun H · 2026 · Journal of Integrative Neuroscience
9. GPR139-mediated cholinergic circuit from the medial septum to the ventral hippocampal CA3 modulates cognitive impairment in Alzheimer's disease
   Huixian Li, Xiaoying Hou, Chi Qin, X Z Li, Xian Wu, Ronghao Mu · 2026 · Neuropharmacology
10. Hierarchical organization of tau topography across the Alzheimer’s disease continuum integrates amyloid, connectome, and intrinsic molecular vulnerability
    Zhi-Ming Zeng, Shu-Shu Han, Qin Liu, Cui-Die Zeng, Xin Jia, Jing Bi, Ling-Chen Liu, Teng-Ao Gao, Lei Liang, Fang-Xiao Cheng · 2026 · Communications Biology
11. N-terminal modifications as fate switches in neurodegeneration: a mechanistic review
    Disha Mukherjee, Sampath Raghul Kannan, Ramasamy Tamizhselvi · 2026 · Frontiers in Aging Neuroscience
12. Synergetic inhibition of deubiquitinases and acetyltransferases to regulate tau acetylation and aggregation in SH-SY5Y cell line model of Alzheimer’s disease
    Basavaraju K C, Harshitha D K, Poornima Priyadarshini C. G. · 2026 · Methods in enzymology on CD-ROM/Methods in enzymology
13. Associations of plasma metabolites with protein biomarkers linked to Alzheimer’s disease pathology in the Rotterdam Study
    Midas M. Kuilman, Shahzad Ahmad, Amos C. Pomp, Frank J. Wolters, Rima Kaddurah‐Daouk, M. Arfan Ikram, Mohsen Ghanbari · 2026 · Alzheimer s Research & Therapy
14. Canagliflozin attenuates cognitive deficits in the streptozotocin-induced mouse model of sporadic Alzheimer's disease via modulating PINK1/Parkin signaling pathway and miR-34a expression.
    Rania I. Nadeem, R. H. Sayed, E. Elbaz, Amina A. S. Abdel Rahman, M. Saeed · 2026 · Progress in Neuro-psychopharmacology and Biological Psychiatry
15. Protein kinase C in neurodegenerative disorders
    Azadeh Hekmat, Ali Akbar Saboury · 2026 · Elsevier eBooks
16. Bromodomain protein 4 (BRD4) as a central epigenetic regulator in neuropsychiatric and neurodegenerative disorders
    Preeti P. Bhagat, Tanisha G. Sharma, Kamini R Shirasath, Sameer N. Goyal, Sanjay N. Awathale · 2026 · Neuroscience
17. Circulating biochemical signatures of neurodegeneration in Alzheimer’s disease
    Greata Rubavathi Eliazer, Mahesh Kandasamy · 2026 · International review of neurobiology
18. Study of pTau217 and GFAP Levels in Iraqi Male and Female Parkinson's Patients
    Raed Mahmoud Al-Azawee, Ammar H.Al-Qazzaz, Abbas M. Alsaedy, Zeinab M. Al-Rubaei · 2026 · Journal of the Faculty of Medicine Baghdad
19. Isotope-edited ESEEM: A new method for probing copper binding sites in neurodegenerative proteins
    Glenn L. Millhauser, Kevin Singewald, Amanda Smart, Francesca A. Pavlovici · 2026 · Journal of Biological Chemistry
20. An Overview of Dementia and Alzheimer's
    Rahul Trivedi, Rajesh A. Maheshwari, Kinjal Prahaladbhai Patel, Shweta Bhandari, Rajesh Hadia, Swapnil Goyal, Rupesh Soni · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
21. Chronic Lithium Exposure Reshapes PI3K–mTOR-linked Proteostatic Networks in the Hippocampus of an Alzheimer’s Disease Mouse Model
    Caíque de Oliveira Portugal Couto, Maria Luiza Hass das Eiras, João Lucas Juliao de Morais, Carlos Wagner Leal Cordeiro Júnior, Orestes Vicente Forlenza, Vanessa de Jesus Rodrigues de Paula · 2026 · Molecular Neurobiology
22. Autophagy and molecular chaperones in neurodegenerative disease
    Riddhi Upadhyay, Nagaraj Rangappa, Murugan Sevanan, Subashchandrabose Chinnathambi · 2026 · Advances in protein chemistry and structural biology
23. Network pharmacology-based identification of hub genes targeted by ayurvedic formulation Triphala in controlling Alzheimer’s disease by polypharmacological mechanisms
    Shabnam Ameenudeen, Hemalatha Srinivasan · 2026 · In Silico Pharmacology
24. Functional Disability and MMPs in Alzheimer’s Disease
    Nevra Alkanlı, Süleyman Serdar Alkanlı, Arzu Ay · 2026 · Springer eBooks
25. Hydrocephalus beyond cerebrospinal fluid obstruction: systems biology mechanisms and AI-enabled multimodal imaging for precision diagnosis and management
    Zhi-Jian Li, Jian Gao, He-Lu Wang, Wei Zhu · 2026 · European journal of medical research
26. UPLC-ESI-qTOF-MS metabolomic characterization and in vivo neuroprotective activity of Diplotaxis harra ethanolic extract through antioxidant, anti-cholinesterase, and anti-amyloid mechanisms
    Rehab Fikry Taher, Asmaa Sayed Abd Elkarim, Amany A. El‐Fadaly, Mohamed Fayed Abdelhameed, Mona M. Eid, Ahmed F. Essa, Walaa A. El‐Kashak, Ninh The Son, Yasmine H. Ahmed, Abdelsamed I. Elshamy · 2026 · Fitoterapia
27. Synergetic Effect of Intermittent Fasting and Phytocompounds in Alzheimer’s Disease Management an in Silico analysis
    Kratika Verma, Kaustav M. Chatterjee, Tiasha Raha, Sounak Basak, Trupti Patel · 2026 · Studies in Rhythm Engineering
28. PDE4A knockdown rescues alcohol-induced cognitive impairment and synaptic dysfunction via the cAMP/PKA/CREB pathway
    Huan Tu, Rongzhen Sun, Shengyao Ma, Chunxu Li, Mingti Lv, M H Han, Han‐Ting Zhang · 2026 · The International Journal of Neuropsychopharmacology
29. Exploration of the preliminary mechanism of HM568 in AD treatment: From reverse virtual screening to validation
    Yingjie Liu, Tingyuan Fu, Wenyuan Li, Kaiye Peng, Minpeng Li, Wei Li, Yifan Feng, Xia Wu · 2026 · Letters in Drug Design & Discovery
30. Computer‐Aided Drug Design, Synthesis, and In Vitro Safety Evaluation of Carprofen Analogs for Novel Alzheimer’s Disease Therapeutics
    Paola Acosta‐Guzmán, Daniel Santiago Bedoya Malagon, Luisa Fernanda Mercado Coy, Sandra Johanna Morantes, James O. Guevara‐Pulido · 2026 · ChemMedChem
31. Microbes and Microbial Chemical Matter in the Seeding of Alzheimer’s Disease: Prospects for Orthogonal Therapies
    Naveen Kumar, Venkateswarlu Yarlagadda · 2026 · ACS Chemical Neuroscience
32. Neuroinflammation and Drug Treatment of Alzheimers Disesase
    Snehal Dahake, Prathamesh Damkondwar, Bhuvan Rekhi, Sana Qausain · 2026 · IEEE International Conference on Intelligent Technologies for a Sustainable and Inclusive Future (ICITSIF)
33. Repressor Element 1 Silencing Transcription Factor as a central regulator of autophagy and neuroinflammation in Alzheimer's disease
    Patil Ishwar Dilip, Rajni Daksh, Pratyasha Sharma, Saumya Khanna, Sree Lalitha Bojja, Abhishek Kumar Singh, Madhavan Nampoothiri · 2026 · European Journal of Pharmacology
34. Hematological Considerations in Immunotherapy for Alzheimer's Disease
    Ritu Raj Kumar, Rohit Pandey, Sonakshi Antal, Shobha Rani, Md. Sarfraj Alam · 2026
35. Neuroprotective potential of cocoa flavanols: Molecular insights, translational and clinical challenges
    Wasim S. M. Qadi, Djilali Benabdelmoumene, Esraa Adnan Dawoud Dawoud, Xiaohui Tong, Rongchun Han, Faidruz Azura Jam, Ahmed Mediani, Murni Nazira Sarian, Ibrahim Jantan, Hamizah Shahirah Hamezah · 2026 · Journal of Functional Foods
36. Metal ion dyshomeostasis in neurological disorders: from pathological mechanisms to targeted neuroprotective and regenerative strategies
    Mengqiang Yao, Chunlei Xing, Xin Li, Xiaochen Sun, Chenxi Zhang, Xingji You, Su Li · 2026 · Frontiers in Pharmacology
37. Liquid-liquid phase-separated tau colocalizes with and stabilizes Aβ oligomers
    Tina Jacob, Marie P. Schützmann, Laurin Gerhards, Laura Hruby, Gabriel Leprivier, Gültekin Tamgüney, Wolfgang Hoyer · 2026 · Communications Chemistry
38. Real‐world implementation of lecanemab in Korean patients at a tertiary memory clinic: Safety, ARIA risk, and early treatment patterns
    Jaemin Shin, S J Suh, Yu Jeong Park, Seungyun Lee, Jimin Kang, Eun Seong Lee, Hye Na Jung, Inseon Ryoo, Seongin Lee, Jae Seon Eo et al. · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
39. Spiro-Polycyclic Polyprenylated Acylphloroglucinols from Hypericum monogynum and Their anti-Alzheimer’s Disease Effects
    Wenjing Tian, 何守伦, Tingjiya Wang, Shengfei Zhong, Jingyu Sun, Junjie Chen, Xiaoyi Wang, Chunchun Du, Yuhang You, Yingting Lin et al. · 2026 · Journal of Natural Products
40. Emerging Trends and Hot Spots in Tauopathy Research (2003–2025): A Bibliometric Analysis
    Si‐Yao Zhang, Hui-Jie Ren, Hao‐Yu Liu, Shu‐Ying Xu, Yongjun Peng · 2026 · Brain and Behavior
41. Novel cell markers with altered expression in brain aging and Alzheimer's disease: A review
    Ejiofor J. Alobu, Obinna Onwe Uchewa, Augustine Oseloka Ibegbu · 2026 · IBRO Neuroscience Reports
42. A Novel Nogo‐A Receptor Antagonist Peptide Impedes Alzheimer's Disease Pathology by Nogo‐A/ NgR / ROCK Signaling Pathway
    Zheng Zhang, Huimin Tan, Fang Shi, Jiajia Dai, Weilong Ding, Junliang Li, Yuke Wang, Rui Yang, Xinke Xu, Cheng Chen et al. · 2026 · CNS Neuroscience & Therapeutics
43. Neuro-metabolic ageing drives diabetes-associated neurodegeneration: A geroscience and network pharmacology perspective
    Sakshi Tiwari, Bilal Siddiqui, Saman Fatima, Monica Saifi, Imran A. Khan, M.Z. Abdin · 2026 · Ageing Research Reviews
44. Imaging the therapeutic effects of cerebral endothelial cell derived exosome treatment of a preclinical model of Alzheimer’s disease
    Lian Li, Guangliang Ding, Li Zhang, Hao Luo, Edward Boyd, Qingjiang Li, Jasleen Kaur, Manisha Bohara, Michael Chopp, Zheng Gang Zhang et al. · 2026 · Frontiers in Aging Neuroscience
45. Targeting Aberrant Protein-Protein Interactions in Cancer and Neurodegenerative Diseases
    Tyler D. Ball · 2025 · Digital Commons - DU (University of Denver)
46. Challenges in Studying Synapses in Alzheimer's Disease
    Thomas Christian Südhof · 2026 · Annals of Neurology
47. Targeting amyloid and Tau: Antibody therapies for Alzheimer’s disease
    Riddhi Upadhyay, Sangitha, Murugan Sevanan · 2026 · International review of neurobiology
48. Rationally Designed Peptides and Peptoids as Inhibitors of Amyloid-β (Aβ) Aggregation
    Xiaoping Huang, Sijie Ma, Xiang Li, Jie Pan · 2026 · Bioconjugate Chemistry
49. Brain‐Targeting siRNA Delivery to Tackle Alzheimer's Disease
    Qingshan Yang, Zhouchun Chen, Jianchao Zhu, Tianran Chai, Fengjie Tang, Mengyu Fan, Yundong Li, Shuangxi Chen, Yang Liu, Meng Zheng · 2026 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
50. Recent medicinal chemistry efforts of targeting protein kinases for treating neurological conditions of Parkinson's and Alzheimer's diseases
    Rajwinder Kaur, Damanpreet Kaur Lang, Ankita Sood, Thakur Gurjeet Singh, Balakumar Chandrasekaran, Mahmoud A. Al-Sha’er · 2026 · RSC Advances
51. Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation
    Jiaxin Wang, Hong Pu, Lingsheng Peng, Shichang Cai, Qi Ding, Xiaoyong Chen, Yang Liu, Wenchao Xiong, Yumei Liao, Genyun Tang · 2026 · Biochemical and Biophysical Research Communications
52. Stress and dementia
    Hiranmoy Bhattacharya, Pratik Chakraborty, Saikat Dewanjee · 2026 · International review of neurobiology
53. Role of AMPK Signaling in the Neuroprotective Effects of Trehalose in Mice With a Pharmacological Model of Alzheimer’s Disease
    Alexander B. Pupyshev, Marina V. Ovsyukova, Anna A. Akopyan, Michael V. Tenditnik, Т. А. Короленко, Nina I. Dubrovina, Maria A. Tikhonova · 2026 · Frontiers in Bioscience-Landmark
54. Targeting the mitochondrial functional network: Decoding upstream pathological mechanisms and novel therapeutic paradigms for Alzheimer’s disease
    Xiong Li, Rui Wan, Yumeng Wu, Yang Zhao, Xuehua Chen, Yuhua Li, Rui Yang, Dongxian Zhang, Qianqian Li, Chengliang Luo · 2026 · Ageing Research Reviews
55. A novel morpholine-functionalized flavone-based NIR fluorescent probe for imaging of β-amyloid aggregates and lysosomal viscosity
    Hongbo Sun, 薛景娇, Huiyuan Gong, Wen Luo, Yongmei Zhao · 2026 · Journal of Molecular Structure
56. Virobiome-mediated regulation of microbiota–gut–brain axis signaling and neuroimmune homeostasis
    Alireza Afkhamian, Abolfazl Saffari Natanzi, Mahin Jafaridarabjerdi, Sara Aghaei, Ali Haghjou, Mohammadreza Shafiei, Aysa Hasanzade Bashkandi, Sajjad Shahraki, R. J. Reiter, Hamed Haddad Kashani et al. · 2026 · Cell Communication and Signaling
57. Natural compounds targeting glial activation in Alzheimer’s disease: a review of curcumin, resveratrol, and luteolin
    Nunung Yuniarti, Rani Resdiani, Marlyn Dian Laksitorini, Agung Endro Nugroho, Yasumasa Bessho · 2026 · Exploration of Neuroprotective Therapy
58. Altered EEG-derived functional brain states in Parkinson's disease with mild cognitive impairment
    Yuxin Wang, Zhen Zhang, Jiang Wang, Zhiqi Jiang, Lifang She, Yang Pan, Chen Liu · 2026 · Brain Communications
59. Attenuation of Tau-Mediated β-Amyloid1-42 Aggregation by Native PLGA Nanoparticles and Its Relevance to Alzheimer Disease Pathology
    Pallabi Sil Paul, Aliza Borenstein-Katz, Klinton Shmeit, Holger Wille, Satyabrata Kar · 2026 · International Journal of Molecular Sciences
60. Integrated proteomics and network pharmacology reveal autophagy-lysosomal regulation underlying sulforaphane-mediated neuroprotection in Alzheimer’s disease
    Yanzhe Li, Chenghao Lu, Nannan Liu, Xinxu Wang, Shen Li · 2026 · Brain Research
61. Altered Membrane Protein Abundance in the Cerebral Cortex of the JNPL3 Mouse Model of Tauopathy
    Sabrina Petralla, Jooseppi Hyvärinen, Mikko Gynther, Alexey Afonin, Marko Lehtonen, Seppo Auriola, Maria Panayotova, Katja M. Kanninen, Gert Fricker, Elena Puris · 2026 · Journal of Proteome Research
62. Advances in N ‐ and S ‐Heterocycles as c‐Jun‐N‐Terminal Kinase 3 Inhibitors for Alzheimer's Disease Treatment
    Praduman Yadav, Deepak Mishra, Ram Singh · 2026 · Drug Development Research
63. Temporal Trajectories of the Tau Aggregate Interactome Reveal Stage‐Specific Vulnerabilities in Alzheimer's Disease
    Dorothea Böken, Paula Beltran-Lobo, Yunzhao Wu, Lyla A. Rowe, Emre Fertan, Cara L. Croft, María Jiménez-Sánchez, Dezerae Cox, David Klenerman · 2026 · Advanced Science
64. Gene therapy in Alzheimer’s disease (AD)
    Maryam Bemanalizadeh, Mitra Ashrafi, Mahdieh Eslami, Shiva Moein, Asad Kazemi, Vahid Mansouri · 2026 · Elsevier eBooks
65. Targeting the BACE1–GSK-3β Signaling Axis in Alzheimer’s Disease: From Molecular Crosstalk to Nanotechnology-Based Translational Strategies
    Anitha Marimuthu, Madhu Tanya Singh, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy · 2026 · Molecular Neurobiology
66. Unlocking the blood–brain barrier: Can low-intensity focused ultrasound enable effective delivery of anti-amyloid and anti-tau antibodies in Alzheimer’s disease?
    Desale, Sakshee Hemant, Doshi, Pratik Prashant, Khutale, Aarti Ashok, Suresh, Swathi · 2026 · Ageing Research Reviews
67. Nuclear Medicine-Based Diagnosis and Therapeutic Strategies for Neurodegenerative Diseases: Clinical Progress.
    Yi Li, Ke Pu, De-Qiang Li, Yi-Jin Zhao, Qi-Xin Cai, Xin Zhou, Shao-Qing Li, Yue Chen, Zhi-Jun Zhou, Yang Liu · 2026 · Ageing Research Reviews
68. Clockophagy in Alzheimer’s Disease: An Emerging Hypothesis Linking Circadian Dysfunction to Ferroptotic Vulnerability
    Jianqin Mao, Yudan Zhang, Ping Wang, Dongdong Qin · 2026 · Cells
69. Gut Microbiome-Mediated Neuroprotective Effect of the Mediterranean Diet: A Narrative Review of Cognitive Aging, Alzheimer’s Disease, and Parkinson’s Disease
    Kundun Kamalakar, Christa A Akerele, Ezequiel Lafont, Lauren R Koralnik, Caitlin Gilman, Jose Clemente Litran, Jakleen Lee, Jessica Robinson‐Papp, Dolores Malaspina · 2026 · Nutrients
70. The role of acupuncture in the dendritic cell vaccine against Alzheimer's disease
    Yuzhu Hong, Ning Shen, Haiqiang Yang, Ghufran Ahmed, Deepika Regmi, Xiaoyang Lin, Ningyi Guo, Grace Hearn, Darrell R. Sawmiller, Chuanhai Cao · 2026 · Journal of Alzheimer s Disease
71. Pharmacologically induced models of dementia: Еxperimental approaches and applications
    Melis Ahmedova, Silvia Gancheva · 2026 · Scripta Scientifica Medica
72. Intermittent fasting as a therapeutic strategy in Alzheimer’s disease: Understanding of brain-derived neurotrophic factor modulation
    Dnyaneshwar Shrirame, Amol Tatode, Dhiraj Dabhade, Jayshree Taksande, Brijesh Gulabrao Taksande, Omkar Kakade, Milind Umekar · 2026 · Physiology & Behavior
73. Polygala tenuifolia as a multi-target therapeutic candidate for Alzheimer’s disease: Molecular mechanisms and translational perspectives
    Salman Ahmad Khan, Iftakhar Ahmad, Md. Omar Faruk, D Hariharasudhan, Шоира Норжигитовна Баратова, Djalolidinova Shakhlo Djamolidinovna, Tasmia Jahin Mim, Saminov Xusniddin Numonjon O’gli, Renuka Mulik, Abdullah Bin Murad et al. · 2026 · Pharmacological Research - Natural Products
74. Tau phosphorylation from neuronal adaptation to Alzheimer’s disease
    R Trouvé, Patrik Verstreken, Marieke MB Hoekstra · 2026 · Neuron
75. Cannabidiol Alleviates Aβ1–42-Induced Cognitive Deficits and Neuronal Injury Associated with Modulation of the AEA–FAAH–CB1R Axis and BDNF/TrkB Signaling
    Yan Kong, Juan Peng, Jian Sun, Yinglan Nie · 2026 · Biomolecules
76. Cystatin C and its Role in the Neuro-Glial-Vascular Unit: Implications for Cerebrovascular Diseases and Neurodegeneration
    Mingchun Li, Zihao Wang, Zifeng Huang, Xihua Guo, Qing Wang, Xiaobo Wei · 2026 · Neuroscience Bulletin
77. Environmental Influence on Neurochemistry
    Anushka Sharma, Daksh Kumar · 2026 · Royal Society of Chemistry eBooks
78. Alpiniae oxyphyllae Fructus in Alzheimer’s Disease: Multi-Target Mechanisms, Current Evidence, and Future AI-Driven Perspectives
    Qihan Qin, Qingmin Yan, Keyi Zhu, Jingyuan Miao, Miaoxin Yang, Zhenghao Wu, Chenhan Fan, Ping Jiang, Guoqing Wu, Qinwen Wang · 2026 · Molecules
79. Computational protein modeling and engineering
    Mahima Ganguly, Vidhi, Nilkamal Mahanta, Suvamay Jana · 2026 · Elsevier eBooks
80. Dysregulated metal homeostasis in Alzheimer’s disease: From pathological modulators to therapeutic targets
    Jiaoyan Yang, Fan Lou, Wei Sun, Ming Li, Lai Su, Yaqian Wang, 李平安, Jingyang Su · 2026 · Pharmacological Research
81. Stem Cell Therapy in Alzheimer’s Disease: a Scoping Review of Safety, Efficacy and Clinical Insights
    Prabir Maity, Ayush Spandan Nayak, Gracy Sharma, Suhrit Sinha, Kajal Nishad Nanda, Chinmaya Chandra Das, Soumarshi Das, Rajwinder Kaur, Tanmay Bagade · 2026 · Current Stem Cell Reports
82. Targeting insulin resistance with exercise mimetics: A potential therapeutic strategy for Alzheimer's disease
    Huanhuan Shi, Zhiwei Ke, Bo Wang, Xinan Zhang, Yang Gui, Hu Zhang, Rongxiang Liang · 2026 · Experimental Neurology
83. BindingDB Entry 50021742: Psychoplastogenic DYRK1A Inhibitors with Therapeutic Effects Relevant to Alzheimer's Disease.
    BindingDB · 2025 · UC San Diego
84. Global Landscape of Radiopharmaceutical Innovation: Emerging Targets and Molecules
    Can Liu, Siqi Zhang, Xuekai Song, Jieting Shen, Linger Li, Tongtong Zhang, Xindan Hu, Quan Zuo, Qichen Hu, Jie Yan et al. · 2026 · Medicinal Research Reviews
85. Unraveling the role of CARM1 in Alzheimer’s disease: molecular mechanisms and therapeutic potential
    Sunit Kumar Gupta, Khadga Raj Aran · 2026 · Inflammopharmacology